FuboTV Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FuboTV Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $4.27M | Aug 11, 2020 |
| FY2018 | Dec 31, 2017 | $41.0K | Jun 10, 2019 |
| FY2017 | Dec 31, 2016 | $24.0K | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | $964.0K | Apr 10, 2017 |
| FY2015 | Dec 31, 2014 | $790.5K | Nov 22, 2016 |
| FY2012 | Dec 31, 2012 | $0 | Apr 15, 2013 |
| FY2012 | Dec 31, 2011 | $0 | Apr 15, 2013 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.62B | Mar 3, 2025 |
| FY2024 | Dec 31, 2023 | $1.37B | Mar 3, 2025 |
| FY2024 | Dec 31, 2022 | $1.01B | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $638.37M | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | $217.75M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $4.27M | Mar 1, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $33.0K | Apr 17, 2018 |
| FY2017 | Dec 31, 2016 | $18.0K | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | $172.0K | Apr 10, 2017 |
| FY2015 | Dec 31, 2014 | $159.1K | Nov 22, 2016 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($172.25M) | Mar 3, 2025 |
| FY2024 | Dec 31, 2023 | ($287.45M) | Mar 3, 2025 |
| FY2024 | Dec 31, 2022 | ($561.48M) | Mar 3, 2025 |
| FY2022 | Dec 31, 2021 | ($382.84M) | Feb 27, 2023 |
| FY2022 | Dec 31, 2020 | ($570.33M) | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | ($34.36M) | Mar 1, 2022 |
| FY2019 | Dec 31, 2018 | ($10.61M) | Aug 11, 2020 |
| FY2018 | Dec 31, 2017 | $10.47M | Jun 10, 2019 |
| FY2017 | Dec 31, 2016 | ($10.07M) | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | ($7.58M) | Apr 10, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($196.02M) | Mar 3, 2025 |
| FY2024 | Dec 31, 2023 | ($289.35M) | Mar 3, 2025 |
| FY2024 | Dec 31, 2022 | ($411.86M) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | ($328.28M) | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | ($479.90M) | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | ($38.89M) | Mar 1, 2022 |
| FY2019 | Dec 31, 2018 | ($14.96M) | Aug 11, 2020 |
| FY2018 | Dec 31, 2017 | ($1.14M) | Jun 10, 2019 |
| FY2017 | Dec 31, 2016 | ($1.17M) | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | ($3.05M) | Apr 10, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $80.01M | Mar 3, 2025 |
| FY2024 | Dec 31, 2023 | $67.68M | Mar 3, 2025 |
| FY2024 | Dec 31, 2022 | $69.26M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $55.42M | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | $30.19M | Feb 27, 2023 |
| FY2017 | Dec 31, 2016 | $161.0K | Apr 17, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($79.48M) | Mar 3, 2025 |
| FY2024 | Dec 31, 2023 | ($177.62M) | Mar 3, 2025 |
| FY2024 | Dec 31, 2022 | ($316.70M) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | ($195.93M) | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | ($149.02M) | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $1.73M | Mar 1, 2022 |
| FY2019 | Dec 31, 2018 | ($3.15M) | Aug 11, 2020 |
| FY2018 | Dec 31, 2017 | ($612.0K) | Jun 10, 2019 |
| FY2017 | Dec 31, 2016 | ($603.0K) | Apr 17, 2018 |
| FY2013 | Dec 31, 2013 | ($131.4K) | Apr 16, 2014 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.73M | Mar 3, 2025 |
| FY2024 | Dec 31, 2023 | $1.07M | Mar 3, 2025 |
| FY2024 | Dec 31, 2022 | $1.13M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $3.41M | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | $166.0K | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $175.0K | Mar 1, 2022 |
| FY2018 | Dec 31, 2017 | $6.0K | Jun 10, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.08B | Mar 3, 2025 |
| FY2024 | Dec 31, 2023 | $1.23B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $1.28B | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $1.37B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $859.35M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $368.23M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $286.10M | Aug 11, 2020 |
| FY2018 | Dec 31, 2017 | $86.0K | Jun 10, 2019 |
| FY2017 | Dec 31, 2016 | $115.0K | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | $313.0K | Apr 10, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $896.65M | Mar 3, 2025 |
| FY2024 | Dec 31, 2023 | $948.82M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $874.44M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $698.90M | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $236.40M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $145.05M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $53.55M | Aug 11, 2020 |
| FY2018 | Dec 31, 2017 | $3.19M | Jun 10, 2019 |
| FY2014 | Dec 31, 2014 | $519.8K | Apr 3, 2015 |
| FY2014 | Dec 31, 2013 | $407.6K | Apr 3, 2015 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $222.71M | Aug 11, 2020 |
| FY2019 | Dec 31, 2018 | $232.55M | Aug 11, 2020 |
| FY2019 | Dec 31, 2017 | ($3.10M) | Aug 11, 2020 |
| FY2018 | Dec 31, 2016 | ($14.44M) | Jun 10, 2019 |
| FY2017 | Dec 31, 2015 | ($5.37M) | Apr 17, 2018 |
| FY2015 | Dec 31, 2014 | $152.9K | Nov 22, 2016 |
| FY2014 | Dec 31, 2013 | $97.6K | Apr 3, 2015 |
| FY2013 | Dec 31, 2012 | $56.3K | Apr 16, 2014 |
| FY2012 | Dec 31, 2011 | $149.1K | Apr 15, 2013 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $615.40M | Mar 3, 2025 |
| FY2024 | Dec 31, 2023 | $622.82M | Mar 3, 2025 |
| FY2024 | Dec 31, 2022 | $618.51M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $619.59M | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | $478.41M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $227.76M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $149.98M | Mar 25, 2021 |
| FY2015 | Dec 31, 2014 | $319.2K | Nov 22, 2016 |
| FY2014 | Dec 31, 2013 | $319.2K | Apr 3, 2015 |
| FY2014 | Dec 31, 2012 | $319.2K | Apr 3, 2015 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($2.02B) | Mar 3, 2025 |
| FY2024 | Dec 31, 2023 | ($1.85B) | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | ($1.56B) | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | ($1.01B) | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | ($626.46M) | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | ($56.12M) | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | ($21.76M) | Aug 11, 2020 |
| FY2018 | Dec 31, 2017 | ($11.15M) | Jun 10, 2019 |
| FY2017 | Dec 31, 2016 | ($21.63M) | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | ($11.59M) | Apr 10, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $161.44M | Mar 3, 2025 |
| FY2024 | Dec 31, 2023 | $245.28M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $337.09M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $370.97M | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $134.94M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $7.62M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | $31.0K | Aug 11, 2020 |
| FY2018 | Dec 31, 2017 | $77.0K | Jun 10, 2019 |
| FY2018 | Dec 31, 2016 | $77.0K | Jun 10, 2019 |
| FY2017 | Dec 31, 2015 | $48.0K | Apr 17, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Mar 3, 2025 |
| FY2024 | Dec 31, 2023 | (1) | Mar 3, 2025 |
| FY2024 | Dec 31, 2022 | (3) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | (2) | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | (12) | Feb 27, 2023 |
| FY2018 | Dec 31, 2018 | (2) | Jun 10, 2019 |
| FY2018 | Dec 31, 2017 | 7 | Jun 10, 2019 |
| FY2017 | Dec 31, 2016 | (359) | Apr 17, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Mar 3, 2025 |
| FY2024 | Dec 31, 2023 | (1) | Mar 3, 2025 |
| FY2024 | Dec 31, 2022 | (3) | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | (2) | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | (12) | Feb 27, 2023 |
| FY2018 | Dec 31, 2018 | (2) | Jun 10, 2019 |
| FY2018 | Dec 31, 2017 | 0 | Jun 10, 2019 |
| FY2017 | Dec 31, 2016 | (359) | Apr 17, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 339.14M | Mar 3, 2025 |
| FY2024 | Dec 31, 2023 | 299.22M | Mar 3, 2025 |
| FY2021 | Dec 31, 2021 | 153.95M | Mar 1, 2022 |
| FY2021 | Dec 31, 2020 | 91.69M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | 28.91M | Mar 25, 2021 |
| FY2019 | Dec 31, 2018 | 7.53M | Aug 11, 2020 |
| FY2018 | Dec 31, 2017 | 2.66M | Jun 10, 2019 |
| FY2017 | Dec 31, 2016 | 33,940 | Apr 17, 2018 |
| FY2016 | Dec 31, 2015 | 9,376 | Apr 10, 2017 |
| FY2015 | Dec 31, 2014 | 54.24M | Nov 22, 2016 |